Male breast cancer: a nation-wide population-based comparison with female breast cancer

  • Marianne D Lautrup (Creator)
  • Signe S Thorup (Creator)
  • Vibeke Jensen (Aarhus University) (Creator)
  • Susanne Bokmand (Creator)
  • Karen Haugaard (Creator)
  • Inger Højris (Creator)
  • Anne Marie Bak Jylling (Creator)
  • Hjoerdis Joernsgaard (Contributor)
  • Giedrius Lelkaitis (University of Copenhagen) (Creator)
  • Mette H Oldenburg (Creator)
  • Gro M Qvamme (Creator)
  • Katrine Soee (Creator)
  • Peer Moller Christiansen (Creator)

Dataset

Description

Objective: Describe prognostic parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980–2009. Determine all-cause mortality compared to the general male population and analyze survival/mortality compared with Danish female breast cancer patients (FBCP) in the same period. Material and methods: The MBCP cohort was defined from three national registers. Data was extracted from medical journals. Data for FBCP is from the DBCG database. Overall survival (OS) was quantified by Kaplan–Meier estimates. Standardized mortality ratios (SMRs) were calculated based on mortality rate among patients relative to the mortality rate in the general population. The association between SMR and risk factors were analyzed in univariate and multivariable Poisson regression models. Separate models for each gender were used for the analyses. Results: We found a marked difference in OS for the two genders. For the total population of MBCP, 5- and 10-year survivals were 55.1% and 31.7%, respectively. For FBCP, the corresponding figures were 76.8% and 59.3%. Median age at diagnosis for FBCP was 61 years and 70 years for MBCP. By applying SMR, the difference in mortality between genders equalized and showed pronounced age-dependency. For males
Date made available23 Dec 2017
PublisherTaylor & Francis

Cite this